← Leaderboards
Steve M Patrick
University Of Toledo Health Sci Campus
$3,402,444
Attributed
$3,402,444
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $424.4K · FY2010–24$500K$375K$250K$125K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$3,402,444 · 3
By mechanism
R01$3,398,444 · 2
R13$4,000 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Mutation”
- Richard A Gibbs · Baylor College Of Medicine$276,143,183
- David Heimbrook · Leidos Biomedical Research, Inc.$175,834,894
- Randall J Bateman · Washington University$154,391,630
- Eric Martin McDade · Washington University$96,219,353
- Stacey Gabriel · Massachusetts Institute Of Technology$95,141,374
- Tatiana M. Foroud · Indiana Univ-Purdue Univ At Indianapolis$93,475,056
Research focus
MutationDna Repair PathwayPathway InteractionsBaseMalignant NeoplasmsDna RepairDeaminationMismatch RepairNucleotide Excision RepairDrug ResistanceDependenceMediatingAntineoplastic AgentsEnzymesAffectDesignBase Excision RepairsCell LineCancer TherapyCisplatinCrosslinkCytosineApoptosisDna Adducts
Grant awards (13)
Novel role of APOBEC3 enzymes as key mediators of cisplatin sensitivity through aberrant processing of interstrand crosslinks$328,060
R01 · FY2024 · CA · contact PI
Novel role of APOBEC3 enzymes as key mediators of cisplatin sensitivity through aberrant processing of interstrand crosslinks$21,409
R01 · FY2023 · CA · contact PI
Novel role of APOBEC3 enzymes as key mediators of cisplatin sensitivity through aberrant processing of interstrand crosslinks$366,732
R01 · FY2022 · CA · contact PI
Novel role of APOBEC3 enzymes as key mediators of cisplatin sensitivity through aberrant processing of interstrand crosslinks$410,873
R01 · FY2021 · CA · contact PI
Novel role of APOBEC3 enzymes as key mediators of cisplatin sensitivity through aberrant processing of interstrand crosslinks$410,873
R01 · FY2020 · CA · contact PI
Novel role of APOBEC3 enzymes as key mediators of cisplatin sensitivity through aberrant processing of interstrand crosslinks$424,373
R01 · FY2019 · CA · contact PI
Novel Role of Base Excision Repair and Mismatch Repair in Cisplatin Sensitivity$300,636
R01 · FY2014 · GM · contact PI
Novel Role of Base Excision Repair and Mismatch Repair in Cisplatin Sensitivity$157,219
R01 · FY2013 · GM · contact PI
Novel Role of Base Excision Repair and Mismatch Repair in Cisplatin Sensitivity$116,690
R01 · FY2013 · GM · contact PI
Novel Role of Base Excision Repair and Mismatch Repair in Cisplatin Sensitivity$282,093
R01 · FY2012 · GM · contact PI
Novel Role of Base Excision Repair and Mismatch Repair in Cisplatin Sensitivity$282,093
R01 · FY2011 · GM · contact PI
13th Annual Midwest DNA Repair Symposium$4,000
R13 · FY2011 · CA · contact PI
Novel Role of Base Excision Repair and Mismatch Repair in Cisplatin Sensitivity$297,393
R01 · FY2010 · GM · contact PI